Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

22 February 2026 : Review article  

Comparison of Substances in Combined Oral Contraceptives Used in Acne Vulgaris, Hirsutism, Migraine, and Dysmenorrhea

Patrycja Wójcikiewicz ORCID logo ABCDEF 1*, Gabriela Durlej ORCID logo BCDEF 1, Małgorzata Satora ORCID logo BCDEF 1, Rafał Tarkowski ORCID logo AE 2, Krzysztof Kułak ORCID logo AEFG 2

DOI: 10.12659/MSM.949520

Med Sci Monit 2026; 32:e949520

Table 3 Summary of studies describing the effect of hormones from different combined oral contraceptive pills on a migraine.

StudyYear of studyResearch groupSubstance and a doseMain findings
De Leo et al []14 201160 women with menstrual migraine without aura aged 20–3520 μgEE 3 mg DRSPThe 24/4 COC regimen is recommended as the preferred treatment for patients suffering from pure menstrual migraine without aura
Vitali-Silva et al []16 2023486 women with migraine, 205 used COC, 89 used a progestin-only method, and 192 participants did not use any form of hormonal contraception.15, 20, 30, 35 or 40 μg EECOC reduced the chances of women with migraine getting allodynia
DSG – desogestrel; EE – ethinylestradiol; COC – combined oral contraceptive; LNG – levonorgestrel; DRSP – drospirenone.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750